Skip to content
Research Article Open access CC BY 4.0

Assessment of Antibiotics Susceptibility Pattern of Vancomycin Resistant Enterococci Isolated from Clinical Specimens in Port Harcourt

F. O. Ibeh, S. A. Wemedo, N. P. Akani

Journal of Advances in Microbiology · pp. 61–74 · Published 27 Jul 2021

10.9734/jamb/2021/v21i730369

Abstract

Aim: The aim of this study was to assess the prevalence of vancomycin resistance among Enterococcal species isolated from clinical specimens of patients attending two hospitals in Port Harcourt, Rivers State. Study Design: The study employs statistical analysis of the data and interpretation. Place and Duration of Study: Two hospitals which are Meridian hospital Port Harcourt and University of Port Harcourt Teaching Hospital, located in the city of Port-Harcourt, Rivers State were used for this study. Specimen collection lasted for 3 weeks and the analysis was carried out daily and it lasted for six months. Methodology: A total of one hundred and eighteen (118) urine and stool specimens (60 urine and 58 stool specimens) were collected from Fifty nine (59) patients for a period of three months from Meridian hospital and University of Port Harcourt Teaching Hospital, Port-Harcourt, Rivers State. The specimens collected were grouped inpatients and outpatients and were subjected to standard microbiological procedures which include standard plate counts, identification, and sensitivity testing using Kirby-Bauer disk diffusion method, Minimum inhibitory concentration and molecular identification of the isolates. Results: A total of 48 enterococcal isolates were isolated from the different specimens (hospitalized and non-hospitalized patients) of urine and stool specimens. All Enterococcal isolates showed high level of resistance to Ceftazidime and Cefuroxime (100%) followed by cloxacillin (95.8%), augumentin (85.4%) and Ceftriaxone (75.0%). The isolates showed higher sensitive rates to Ofloxacin (95.5%), followed by Gentamicin (77.1%) and Vancomycin (39.6%). All Enterococal isolates from this study had a MAR index > 0.2. A total of the 48 Enterococci were isolated, the 23 (47.9%) isolates were identified as vancomyin resistant during this study were subjected to MIC (Minimum Inhibitory Concentration) for vancomycin as a confirmatory test. Of the 23 isolates, 12 isolates were vancomycin resistant with 11 isolates showing vancomycin MIC values of 8-16μg /ml (vancomycin intermediate). Conclusion: Conclusively, this study revealed varying Antibiotic susceptibility pattern of the isolated bacteria. Treatment guidelines for use of antibiotics should be based on the hospital formulary and the sensitivity patterns is advocated. This should be reviewed occasionally to ensure rational use of antibiotics

Vancomycin enterococcus vancomycin resistant enterococci prevalence.

References (44)

  1. 1 Mechanisms of Antibiotic Resistance [DOI]
  2. 2 Antimicrobial agents and chemotherapy—1969 [DOI]
  3. 3 District Laboratory Practice in Tropical Countries [DOI]
  4. 4 THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [DOI]
  5. 5 Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? [DOI]
  6. 6 Vancomycin Resistance in Gram-Positive Cocci [DOI]
  7. 7 Intrinsic and acquired resistance mechanisms in enterococcus [DOI]
  8. 8 Mechanisms of antibiotic resistance in enterococci [DOI]
  9. 9 Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future [DOI]
  10. 10 Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes [DOI]
  11. 11 Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management [DOI]
  12. 12 Management of multidrug-resistant enterococcal infections [DOI]
  13. 13 Transfer of Vancomycin-Resistant Enterococci via Health Care Worker Hands [DOI]
  14. 14 Emergence of Vancomycin-Resistant Enterococci [DOI]
  15. 15 Vancomycin‐Resistant Enterococci: Mechanisms and Clinical Observations [DOI]
  16. 16 Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting [DOI]
  17. 17 Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates [DOI]
  18. 18 Hand Hygiene for the Prevention of Nosocomial Infections [DOI]
  19. 19 Self medicated antibiotics in Bangladesh: a cross-sectional health survey conducted in the Rajshahi City [DOI]
  20. 20 Vancomycin resistant enterococci in farm animals – occurrence and importance [DOI]
  21. 21 Genetic Characterization of vanG , a Novel Vancomycin Resistance Locus of Enterococcus faecalis [DOI]
  22. 22 Treatment Options for Vancomycin- Resistant Enterococcal Infections [DOI]
  23. 23 Regulation of VanA- and VanB-Type Glycopeptide Resistance in Enterococci [DOI]
  24. 24 The Prevalence and the Characterization of the Enterococcus Species from Various Clinical Samples in a Tertiary Care Hospital [DOI]
  25. 25 Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation [DOI]
  26. 26 Prevalence of Virulence Factors and Vancomycin-resistant Genes among Enterococcus faecalis and E. faecium Isolated from Clinical Specimens.
  27. 27 What’s New in the Treatment of Enterococcal Endocarditis? [DOI]
  28. 28 Clinical and microbiological features of bacteremia caused by Enterococcus faecalis [DOI]
  29. 29 Molecular epidemiology of vancomycin-resistant Enterococcus faecium in Argentina [DOI]
  30. 30 Management of Multi-Drug Resistant Enterococcal Infections [DOI]
  31. 31 Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study [DOI]
  32. 32 BSAC standardized disc susceptibility testing method [DOI]
  33. 33 Epidemiology and molecular typing of VRE bloodstream isolates in an Irish tertiary care hospital [DOI]
  34. 34 Isolation, identification, and antibiogram of enterococci isolated from patients with urinary tract infection [DOI]
  35. 35 Molecular Characterization of Glycopeptide-Resistant Enterococci from Hospitals of the Picardy Region (France) [DOI]
  36. 36 Antimicrobial resistant bacteria among health care workers in intensive care units at Ain Shams University Hospitals.
  37. 37 Molecular Typing of Enterococci/Vre [DOI]
  38. 38 SURVEILLANCE FOR VANCOMYCIN RESISTANT ENTEROCOCCI IN A TERTIARY INSTITUTION IN SOUTH WESTERN NIGERIA [DOI]
  39. 39 Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.
  40. 40 Treatment of Vancomycin-Resistant Enterococcus faecium Infections [DOI]
  41. 41 Frequency of VanA, VanB and VanH variants amongst vancomycin-resistant enterococci isolated from patients in central region of Iran.
  42. 42 Comparative studies of methods of Salmonella enrichment.
  43. 43 Infection Control in Intensive Care Units [DOI]
  44. 44 African Journal of Infectious Diseases [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

41

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.